News

A new study shows mRNA-based treatment can protect muscle tissue from snake venom damage, offering a potential boost to current antivenoms. The method produced antibodies within hours and reduced injury in preclinical models.

New research has shown how pro-tumor macrophages can be re-educated with immune-activating molecules.

Researchers transplanted a single-edit α-Gal knockout pig kidney and thymus into a brain-dead recipient, followed by 61 days of monitoring. The organ produced urine, maintained electrolyte balance and withstood antibody-mediated rejection.

Researchers are working to create an artificial cartilage that resembles natural cartilage, with a recipe that can be adjusted along the way.

A new vaccine targeting the deadly Crimean-Congo hemorrhagic fever virus shows rapid protection in mice, working within days and lasting over a year.

Dual-target CAR-T cells attacking tumor cells and their matrix show strong efficacy in glioblastoma models, supporting upcoming clinical trials.

A new patch developed by Texas A&M University researcher Dr. Ke Huang may offer a way to help the heart heal after a heart attack. The patch uses a unique microneedle system to deliver a therapeutic molecule directly to damaged heart tissue.

Researchers say the molecule, called P-selectin, could turn the tide to develop a new generation of mRNA therapies to combat not just COVID variants, but also other viruses in the same family.

An international team of researchers led by UMC Utrecht has developed two new antibodies that can cleverly inhibit the immune system.

A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease.